Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.5K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

24.0K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.0K
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation02:17

Reduction of Alkenes: Asymmetric Catalytic Hydrogenation

3.8K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.8K
Coordination Number and Geometry02:57

Coordination Number and Geometry

18.9K
For transition metal complexes, the coordination number determines the geometry around the central metal ion. Table 1 compares coordination numbers to molecular geometry. The most common structures of the complexes in coordination compounds are octahedral, tetrahedral, and square planar.
18.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Heterometallic Multinuclear Ruthenium Complexes as Cytotoxic Agents.

Biomedicines·2026
Same author

Recent Advances in Anticancer Research of Osmium and Rhodium Complexes.

Medicinal chemistry (Shariqah (United Arab Emirates))·2025
Same author

The Spectroscopic Characterization and Photophysical Properties of a Hydrated Lanthanum Ion Complex with a Triazole Ligand by Several DFT Methods.

Molecules (Basel, Switzerland)·2025
Same author

Cytotoxic Organometallic Iridium(III) Complexes.

Molecules (Basel, Switzerland)·2025
Same author

Special Issue: "Rational Design and Synthesis of Bioactive Molecules".

International journal of molecular sciences·2024
Same author

Effect of Lanthanide Ions and Triazole Ligands on the Molecular Properties, Spectroscopy and Pharmacological Activity.

International journal of molecular sciences·2024

相关实验视频

Updated: Jan 17, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.4K

同金属多核复合体在抗癌药物开发中的应用.

Irena Kostova1

  • 1Department of Chemistry, Faculty of Pharmacy, Medical University-Sofia, 2 Dunav St., Sofia 1000, Bulgaria.

Mini reviews in medicinal chemistry
|September 15, 2025
PubMed
概括

多核化合物显示出作为抗癌剂的前景. 这些金属复合物提供了增强的疗效和选择性,扩大治疗潜力超出单金属药物.

科学领域:

  • 药用化学 医学化学
  • 无机化学 无机化学
  • 药物开发 药物开发

背景情况:

  • 西斯的成功刺激了对金属基抗癌剂的研究.
  • 研究IXB组金属 (Rh,Ir,Pd) 和它们的复合物,以检测它们的抗瘤特性.
  • 多金属复合物提供协同效应和改善生物分布.

研究的目的:

  • 审查用于癌症治疗的多核同金属化合物的最新进展.
  • 突出以为基础的复合物作为抗瘤剂的潜力.
  • 为了解决多核Rh基化合物的研究不足的性质.

主要方法:

  • 在癌症研究中对多核复合物的文献综述.
  • 分析着重于结构和功能多样性的研究.
  • 对细胞毒性作用,细胞内分布和选择性的评估.

主要成果:

  • 多核化合物表现出增强的细胞毒性作用.
  • 这些复合体表现出更好的细胞内分布和选择性.
  • 基于的化合物显示出多功能药物开发的前景.

结论:

关键词:
罗狄 罗狄 是一种这是一种抗癌药物.复杂的复杂的复杂.药物发展. 药物开发.同金属的同金属化它们是多核的.

更多相关视频

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.7K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.7K

相关实验视频

Last Updated: Jan 17, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.4K
The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.7K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.7K
  • 多核复合体是新型抗癌疗法的有希望的候选者.
  • 对这些化合物的进一步研究可能会导致先进的候选药物.
  • 它们的独特特性比单核金属复合物具有优势.